PFIZER ApS: Financial statements 2013
CVR: 66351912
Source: annual report 2013, Danish Business Authority
01/12/2012 – 30/11/2013
PFIZER ApS (CVR 66351912) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 836,267,000 and a net result of DKK 32,044,000. The profit margin was 3.8%. Equity in the 2013 report amounted to DKK 470,133,000. The solvency ratio was 61.2%. The company had 132 employees in the financial year.
- Revenue
- DKK 836,267,000
- Profit/Loss
- DKK 32,044,000
- Equity
- DKK 470,133,000
- Total Assets
- DKK 767,651,000
- Employees
- 132
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of June 30, 2013, Kristin Jo Blomquist has joined the board of directors of PFIZER ApS.
PFIZER ApS has published its annual report for 2012.
As of April 30, 2013, Kamila Katarzyna Kozikowska has joined the board of directors of PFIZER ApS.
As of April 30, 2013, Robert Graeme Pinder has left the board of directors of PFIZER ApS.
About PFIZER ApS
PFIZER ApS is a Danish company of the type Anpartsselskab based in Ballerup, founded in 1956. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Kjetil Hagen. The board consists of Anne Bloch Thomsen (chair), Hans Henrik Buur and Kjetil Hagen. The company is owned by Pfizer Health AB. The company has 148 employees (2018). In 2025, the company reported revenue of DKK 683,240,000 and a net result of DKK 13,956,000 compared with DKK 13,103,000 the year before. Equity in the 2025 report amounted to DKK 315,053,000.